Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1262681-31-1

C21H35N3O6S is a chemical compound with a molecular formula indicating the presence of carbon, hydrogen, nitrogen, oxygen, and sulfur atoms. C21H35N3O6S is likely to have various applications across different industries due to its unique structure and properties.

1262681-31-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

  • 5-[(3aR,4R,6aS)-2-oxo-hexahydrothieno[3,4-d]imidazol-4-yl]-N-(3,6,9,12-tetraoxapentadec-14-yn-1-yl)pentanamide

    Cas No: 1262681-31-1

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • 1262681-31-1 Structure

  • Basic information

    1. Product Name: C21H35N3O6S
    2. Synonyms: C21H35N3O6S
    3. CAS NO:1262681-31-1
    4. Molecular Formula:
    5. Molecular Weight: 457.591
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1262681-31-1.mol

  • Chemical Properties

    1. Melting Point: 55-64 °C
    2. Boiling Point: 707.1±60.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: 1.158±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C21H35N3O6S(CAS DataBase Reference)
    10. NIST Chemistry Reference: C21H35N3O6S(1262681-31-1)
    11. EPA Substance Registry System: C21H35N3O6S(1262681-31-1)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1262681-31-1(Hazardous Substances Data)

1262681-31-1 Usage

Uses

Used in Biomaterials and Tissue Engineering:
C21H35N3O6S is used as a component in the development of biomaterials and tissue engineering applications for its ability to interact with biopolymers and macromolecules. This makes it a promising candidate for creating advanced materials that can be used in regenerative medicine and other related fields.
Used in Drug Delivery Systems:
In the pharmaceutical industry, C21H35N3O6S is used as a component in drug delivery systems. Its unique chemical structure allows for the development of novel drug carriers that can improve the bioavailability and therapeutic efficacy of various medications.
Used in Chemical Reactions:
C21H35N3O6S is utilized as a reactant or catalyst in specific chemical reactions, particularly those involving bioorthogonal azide-alkyne cycloaddition reactions. This allows for the creation of new materials and compounds with tailored properties for various applications.
Used in Research and Development:
In the field of scientific research, C21H35N3O6S serves as a valuable compound for studying the interactions between different molecules and understanding the underlying mechanisms of various biological processes. This knowledge can be applied to develop new therapeutic strategies and materials with improved performance.

Check Digit Verification of cas no

The CAS Registry Mumber 1262681-31-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,2,6,8 and 1 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1262681-31:
(9*1)+(8*2)+(7*6)+(6*2)+(5*6)+(4*8)+(3*1)+(2*3)+(1*1)=151
151 % 10 = 1
So 1262681-31-1 is a valid CAS Registry Number.

1262681-31-1Downstream Products

1262681-31-1Relevant articles and documents

KETONE INHIBITORS OF LYSINE GINGIPAIN

-

Paragraph 0417, (2018/04/12)

The present invention provides compounds according to Formula (I) as described herein, and their use for inhibiting the lysine gingipain protease (Kgp) from the bacterium Porphyromonas gingivalis. Also described are gingipain activity probe compounds and methods for assaying gingipain activity are also described, as well as methods for the treatment of disorders associated with P. gingivalis infection, including brain disorders such as Alzheimer's disease.

In vivo programming of endogenous antibodies via oral administration of adaptor ligands

Nagano, Masanobu,Carrillo, Nancy,Otsubo, Nobumasa,Hakamata, Wataru,Ban, Hitoshi,Fuller, Roberta P.,Bashiruddin, Nasir K.,Barbas, Carlos F.

supporting information, p. 5952 - 5961 (2017/10/10)

Vaccination is a reliable method of prophylaxis and a crucial measure for public health. However, the majority of vaccines cannot be administered orally due to their degradation in the harsh gut environment or inability to cross the GI tract. In this stud

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1262681-31-1